Integra Lifesciences Holdings Corp financial data

Symbol
IART on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
1100 Campus Road, Princeton, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INTEGRA LIFESCIENCES CORP (to 3/31/1999)
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 339 % -9.84%
Quick Ratio 113 % +3.77%
Debt-to-equity 138 % +14.1%
Return On Equity 2.5 % -75.1%
Return On Assets 1.05 % -76.9%
Operating Margin 5.17 % -64.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.8M shares -3.79%
Entity Public Float 3.26B USD -16.8%
Common Stock, Value, Issued 915K USD +0.77%
Weighted Average Number of Shares Outstanding, Basic 77.7M shares -5.05%
Weighted Average Number of Shares Outstanding, Diluted 77.7M shares -5.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.53B USD -2.07%
Costs and Expenses 1.45B USD +8.84%
Operating Income (Loss) 79.1M USD -65.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 46.1M USD -77.5%
Income Tax Expense (Benefit) 5.83M USD -82.1%
Net Income (Loss) Attributable to Parent 40.2M USD -76.6%
Earnings Per Share, Basic 0.51 USD/shares -75.6%
Earnings Per Share, Diluted 0.51 USD/shares -75.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 592M USD +92.6%
Accounts Receivable, after Allowance for Credit Loss, Current 241M USD -5.08%
Inventory, Net 403M USD +14.8%
Other Assets, Current 35.4M USD
Assets, Current 1.42B USD +37.5%
Deferred Income Tax Assets, Net 34.2M USD -23.5%
Property, Plant and Equipment, Net 345M USD +9.58%
Operating Lease, Right-of-Use Asset 152M USD +3.63%
Intangible Assets, Net (Excluding Goodwill) 1.02B USD -7.77%
Goodwill 1.04B USD -0.13%
Other Assets, Noncurrent 68.4M USD +21.7%
Assets 4.08B USD +8.97%
Employee-related Liabilities, Current 52.6M USD -1.92%
Accrued Liabilities, Current 112M USD +19.9%
Contract with Customer, Liability, Current 7.84M USD +1.27%
Liabilities, Current 302M USD +7.12%
Contract with Customer, Liability, Noncurrent 6.9M USD -21.6%
Deferred Income Tax Liabilities, Net 31.4M USD -49.1%
Operating Lease, Liability, Noncurrent 170M USD +8.4%
Other Liabilities, Noncurrent 140M USD +10.2%
Liabilities 2.48B USD +20%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10.6M USD -251%
Retained Earnings (Accumulated Deficit) 944M USD +4.45%
Stockholders' Equity Attributable to Parent 1.6B USD -4.6%
Liabilities and Equity 4.08B USD +8.97%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.8M USD -39.8%
Net Cash Provided by (Used in) Financing Activities 359M USD
Net Cash Provided by (Used in) Investing Activities -54M USD -294%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 91.5M shares +0.74%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 316M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 592M USD +92.6%
Deferred Tax Assets, Valuation Allowance 12.5M USD +29.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 240M USD +13.8%
Operating Lease, Liability 186M USD +8.55%
Depreciation 40.9M USD +2%
Payments to Acquire Property, Plant, and Equipment 15.5M USD +12.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 22.5M USD -88.7%
Lessee, Operating Lease, Liability, to be Paid 277M USD +7.85%
Property, Plant and Equipment, Gross 708M USD +10.4%
Operating Lease, Liability, Current 16.3M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.5M USD +2.28%
Lessee, Operating Lease, Liability, to be Paid, Year One 23.2M USD +8.29%
Deferred Income Tax Expense (Benefit) -2.86M USD -246%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 91M USD +6.44%
Lessee, Operating Lease, Liability, to be Paid, Year Three 19.2M USD +10%
Deferred Tax Assets, Operating Loss Carryforwards 28.8M USD -6.21%
Deferred Federal Income Tax Expense (Benefit) -19.1M USD -64.4%
Current Income Tax Expense (Benefit) 25.2M USD -33.5%
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 812K USD +13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.9M USD +2.41%
Operating Lease, Payments 5.73M USD +32.8%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 2.85M USD -25.7%
Current Federal Tax Expense (Benefit) 11M USD -54.7%
Amortization of Intangible Assets 19.4M USD +47.9%
Deferred Tax Assets, Net of Valuation Allowance 227M USD +13%
Share-based Payment Arrangement, Expense 20.1M USD -27.4%
Deferred State and Local Income Tax Expense (Benefit) 93K USD
Interest Expense 52.9M USD +5.72%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares